🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the relative bioavailability of a new...
Status
Completed
Location
Syneos Health Clinic inc.
Start Date
2024-02-23
Trial ID
NCT06284902
Treatments Being Tested
Primary Objective: Determine blood concentrations of two formulations of RE...
Status
Completed
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02741739
Treatments Being Tested
This is a single-dose, open-label, randomized, four-period, four-treatment,...
Status
Completed
Location
Worldwide Clinical Trials Early Phase Services, LLC
Start Date
2020-01-14
Trial ID
NCT04309656
Treatments Being Tested
The purpose of this study is to demonstrate bioequivalence on the primary p...
Status
Completed
Location
Celerion
Start Date
2020-01-17
Trial ID
NCT04235270
Treatments Being Tested
To compare the bioavailability of a single 400 mg dose of certolizumab pego...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00845663
Treatments Being Tested
The purpose of this study is to establish bioequivalence of Lu AF35700 betw...
Status
Completed
Location
Covance
Start Date
2018-01-03
Trial ID
NCT03394482
In this trial, 32 healthy subjects are planned to be enrolled in fasting an...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-17
Trial ID
NCT05976737
The purpose of this study is to compare how two different formulations of t...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-07-17
Trial ID
NCT07712393
Treatments Being Tested
The purpose of this study is to determine the relative bioavailability of C...
Status
Completed
Location
Clinical Pharmacology Unit
Start Date
2022-08-24
Trial ID
NCT05526742
Treatments Being Tested
Single-rising dose (SRD) part: The main objectives of the SRD part of this...
Status
Terminated
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2025-11-21
Trial ID
NCT07250048
Treatments Being Tested